Neil Flynn
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Regulation of Appetite and Obesity, RNA Interference and Gene Delivery, Biochemical Analysis and Sensing Techniques, Growth Hormone and Insulin-like Growth Factors
Most-Cited Works
- → 2-Hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors(2007)91 cited
- → Enhanced Gastrointestinal Motility with Orally Active Ghrelin Receptor Agonists(2009)60 cited
- → Design, synthesis and structure–activity relationships of azole acids as novel, potent dual PPAR α/γ agonists(2009)35 cited
- → Discovery of Pyrrolidine-Containing GPR40 Agonists: Stereochemistry Effects a Change in Binding Mode(2017)30 cited
- → Discovery of a Tetrazole-Based Growth Hormone Secretagogue: 4-(Hydroxybutyl)carbamic Acid 2-{5-[1-(2-Amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl Ester (BMS-317180)(2007)28 cited
- → Discovery, synthesis, and structure–activity studies of tetrazole based growth hormone secretagogues(2007)25 cited
- → Tetrahydroisoquinoline 1-carboxamides as growth hormone secretagogues(2005)20 cited
- → Identification of a Nonbasic Melanin Hormone Receptor 1 Antagonist as an Antiobesity Clinical Candidate(2014)20 cited
- → Design and synthesis of tetrazole-based growth hormone secretagogue: The SAR studies of the O-benzyl serine side chain(2008)19 cited
- → Synthesis and Antiobesity Properties of 6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2- d ]pyrimidin-4(3 H )-one (BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 (MCHR1) Inhibitor(2016)15 cited